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HYPOFIBRI OGE AEMIA
WITH SPECIAL REFERE CE TO SEVERE CO CEALED CCIDENTAL HAEMORRHAGE
TERENCE RocKEY: M.B., B.S., D.ODST. R.C.O.G., and DERK CRICHTON, D.PHIL., ER.C.. (Em .), F.R.C.O.G.
Department of Gynaecology, University of alal
One of the few major advances in the practice of obste-
trics in the la t decade has been the discovery of coagula-
tion defects in pregnancy associated mainly with a
reduction or lack of fibrinogen in the pia ma.
As long ago as 1769 Morgani noticed that blood some-
times failed to clot at necropsy, and Hunter in 1794
observed that blood was deprived of its power of coagula-
tion in cases of sudden death. Early in the present century
Blair BeW found that menstrual blood contained neither
fibrin ferment nor fibrinogen, but it was only in 1936 that
Dieckmann' first indicated the true nature of the coagula-
tion defect in association with abruptio placentae. Sin e
then a similar coagulation defect has been described in
many different circumstances_
In obstetric practice thi hypofibrinogenaemia i mo t
commonly associated with severe forms of accidental
haemorrhage, less commonly following an intra-uterine
foetal death of some standing, and rarely with amniotic-
fluid embolism.
It has also been described following incompatible blood
transfusions," and ruptured uterus.' Recently Beischer" ha
described the condition occurring after apparently normal.
deliveries, and Winch and Bryans· have described one
case associated with a retained intra-abdominal placenta
after removal of an extra-uterine pregnancy.
Whilst it is not the purpose of this paper to discuss the
exact mechanisms of the mode of production of this
hypofibrinogenaemia, it is worth mentioning that three
main theories exist, of which none is entirely satisfactory:
I. A thromboplastin theory, where it is postulated that
thromboplastins are absorbed from the liquor amnii and
uterine tissues, causing a widespread deposition of fibrin
emboli in the vascular bed. .
2. A fibrinolysin theory, which postulates the relea e
of fibrinolysins from a damaged uterine muscle which
inactivate or dissolve the available circulating fibrinogen.
3. A theory in which it is thought that a large portion
of the available fibrinogen is used up at the site of the
retroplacental clot. with perhaps a subsequent release of
fibrinolysins.
THE PRESENT INVESTIGATION
70 patients with severe accidental haemorrhage (abruptio
placentae) were found among 26,478 patients delivered in
the Obstetric Unit of the University of Natal at King
Edward VIII Hospital between 1 January 1958 and 31
December 1959. Only severe cases of accidental hae-
morrhage, where there was evidence of shock. intra-uterine
death, and acute abdominal tenderness, were included.
DisCllssion of the Findings
The in idence of evere accidental haemorrhage was
higher than described el ewhere in the literature, being no
less than 0'3'10' imilarly, the in idence of a erious clotting
defect among the 70 patients in this eries was high, being
62% (43 ca es).
aturaUy, the incidence of hypofibrinogenaemia a so-
ciated with accidental haemorrhage will vary according
to the criteria u ed in its diagnosi . Thus Barry et at: in
Dublin stated that 'the clotting defect is to be found in the
majority of. if not all, case of combined and concealed
haemorrhages', whereas Beischer" found a clotting defect
in 3.5 % of patients with accidental haemorrhages, and
Porter
O
an incidence of 42%.
Of our 46 cases of hypofibrinogenaemia, 44 were
associated with abruptio placentae. One was associated
with an intra-uterine death at 30-weeks period of gestation,
and I wa associated with a ruptured uterus which
developed after a Caesarean hy terectomy had been per-
formed. The incidence of hypofibrinogenaemia per total
deliveries was 0·18%, which is 18 times higher than that
found by Scott9 in Liverpool.
Increa ing parity appeared to predi po e to hypofibrino-
genaemia. for there were only 8·9% (4) primigravid, 63%
(29) para 1 - 4, and as many as 28·2% (13) grande multi-
parous (5 or more pregnancies) patients in the present
series. whereas the incidence of primiparae, multiparae
and grande multiparae in the general run of deliveries wa
29%. 56%. and 17% respectively.
Although it is traditional to associate hypertension or
pre·eclampsia with abruptio placentae, the as Deiation is
often impossible to establish in the presence of hock, and
in many of our patients the hypertension did not become
manifest until after resuscitation of the patient. Eastman'O
i of the opinion that 'with each pas iog hour abruptio
onduces more and more to hypertension and albuminuria'.
It is not urprising, therefore, that the incidence of
toxaemia in abruptio placentae i uncertain - being
reported for instance by Kimbrough1l as '10' and a 66%
by Adam ." In the present eries definite evidence of
hypertension with or without uperimpo ed toxaemia wa
found in but 29% (13 cases), which contributes little to
olve 'which is the horse and which i the wagon'.
Barry' ha uggested that malnutrition and anaemia are
important associated factors, and Kwaan et al." have
hown that an increased fibrolytic activity i a sociated
with cirrho i of the liver. Certa,inly in our patients hypo-
proteinaemia, an inverted albumin/globulin ratio, and
z
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minor liver dysfunction are 'normal' findings, malnutrition
being rife; but anaemia per se is comparatively rare in
the African.
However, their fibrinogen levels are normal and their
fibrinolytic activity is lowered during pregnancy." The
effect of this liver dysfunction on the clotting mechanism
is at present undergoing investigation. These factors may
possibly explain the relative frequency of hypofibrinoge-
naemia in our practice.
An important point lies in the previous history of acci-
dental haemorrhage. Porter8 found the incidence of
abruptio placentae in a subsequent pregnancy was as high
as 12% and Fyfe and Grant'" describe a case of afibrino-
genaemia in two successive pregnancies. Only one of our
patients had a history of having had a previous antepartum
haemorrhage.
A further important consideration is a history of a
small antepartum haemorrhage at an earlier stage of the
pregnancy. Two of our patients had been discharged fol-
lowing investigation for a small antepartum haemorrhage
after placentography had demonstrated a normally
situated placenta, only to be readmitted later, having had
a severe accidental haemorrhage.
The Diagnosis of HYPofibrinogenaemia
The first prerequisite in the diagnosis of hypofibrino-
genaemia is to be aware of its existence and suspect its
presence in all patients with severe accidental haemorrhage
and all patients with a bleeding tendency, either in preg-
nancy or immediately after delivery. Even then there may
be a considerable delay in diagnosis.
Numerous qualitative and quantitative tests have been
described in the investigation of the bleeding tendency. We
have found Weiner's clot-observation test the most useful
and this is carried out as a routine in every patient with
antepartum haemorrhage. This test has the advantage of
simplicity and rapidity. However, Sharp et al."° consider
that tests based on the reactivity of plasma to purified
thrombin are the most reLiable.
In every patient where a clinical possibili,ty of a clotting
defect existed or was suspected on the clot-observation
test, a routine quantitative estimation of the fibrinogen
level was performed, using the method described by Stir-
land, in 1956."7 Where doubt remained reliance was' pri-
marily placed on the bedside tests. A modified Schneider
test was also performed in equivocal cases. These tests
were repeated hourly, as necessary, during the treatment
of the patient. Where error in diagnosis occurred, it
resulted from failing to perform the tests rather than from
any inaccuracy in the results.
Tests for a heparin-like factor and circulating fibrinoly-
sins (other than the clot-observation test) have not been
performed as a routine up to the present.
Treatment
The treatment of hypofibrinogenaemia varies greatly
from centre to centre. We have found the following
routine to give the most satisfactory results:
In the vast majority of patients with severe accidental
haemorrhages of sudden ons~t we have found that there
are at least 2 - 3 pip·ts of retroplacental blood clot. We
believe, therefore, that 2 - 3 pints of blood can be trans-
fused rapidly in these cases with safety, to restore the blood
volume and thus prevent the danger of renal arteriolar
s'pasm with subsequent renal damage. Calcium gluconate
is given with the blood as required, to counteract possible
citrate effects.
The slow pulse often found, even in patients with severe
accidental haemorrhage, tends to give the unwary a false
sense of security, whereas these patients should neverthe-
less be treated along the routine lines. If hypovolaemia
is not corrected, then a further small haemorrhage may
easily precipitate a state of profound shock.
Additional defects in other sections of the clotting
mechanism may also assume dominant roles in recalcitrant
cases, and 'fresh' blood, while not containing more
fibrinogen than stored blood, may be beneficial.
At the same time as the blood volume is being restored,
fibr,inogen is replaced as required, either in the form of
triple-strength plasma containing about 3 G. per unit,' or
as purified human fibrinogen. Of the two, our recent pre-
ference is for the purified fibr,inogen since it requires less
volume, weight for weight, and the fibrinogen content is
more accurately known. leffcoate and 5oott"8 have sug-
gested that plasma may be more effective than fibrinogen.
However, this has not been our experience; indeed, we are
opposed to it since we have observed a tendency to hyper-
volaemia and subsequent pulmonary oedema with its use.
The hypovolaemia and the clotting defect should be
corrected simultaneously, lest by raising the blood pressure
without controlling the coagulation defect, further and
possibly fatal haemorrhage may be precipitated.
We have found that certain patients require very large
amounts of fibrinogen to restore the clotting mechanism
to normal. In such patients intravenous cortisone may be
helpful, according to Moore; in order to speed the com-
bination of plasmin (fibrinolysin) with an anti-plasmin,
thus reduoing fibrinolytic activity which may be increased
in the presence of profound shock.
Our exper,ience agrees with the leading article in the
British Medical Journal's that defibrination is usually 'a
once for all mechanism', but if the interval between the
onset of haemorrhage and the delivery becomes prolonged,
particularly in African patients, a recurrence of the clotting
defect oHen occurs.
We have never found any evidence of an intravascular
fibrin deposition of sufficient magnitude to produce any
signs ei,ther during the delivery or in the puerperium, and
so have not. considered the use of heparin.
The amount of f'ibrinogen used depends on the progress
of the clotting defect. Barnett and Cussen'· have found
very small doses of fibrinogen to be effective in some
patients, but others give 4·8 G. empirically. We have
found anything less than an initial dose of 3 G. inadequate
in the type of patient under consideration.
Once ,the hypovolaemia and clotting defect have been
corrected, then, and only then, is an effort made to
expedite delivery, which is done by artificially rupturing
the membranes. Immedia.te rupture of the membranes, as
advocated by some authorities, is dangerous in serious
cases.
If, one hour after rupture of the membranes, the patient
shows no signs of going into labour, despite the presence
of a cervix which is not too unfavourable, a pitocin infu-
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sion of 1 part in 2,500 is given to stimulate labour. In
the majority of patients these measures result in a rapid
onset of labour. If, after 4 hours on a pitocin drip, labour
i not well established and making good progress, the
pregnancy is usually terminated by lower-segment
Caesarean section, after again checking that the blood
defect has remained corrected.
There are of course dangers in the use of pitocin and
cases of high multiparity should be excluded. The
theoretical danger of increasing the incidence of anuria
has not been borne out in our series.
Obstetrical complications, such as malpresentation and
cephalopelvic disproportion, are treated on their merits
with early recourse to Caesarean section if there are signs
of a difficult delivery ahead. Caesarean section is also
performed in patients where there is evidence of a recur-
rence of the clotting defect, after again correcting this
defect.
The one patient in whom intra-uterine death was asso-
ciated with hypofibrinogenaemia was treated conservatively
in this series by awaiting the spontaneous onset of labour
and then rapidly correcting the coagulation defect. If,
however, the bleeding tendency causes serious symptoms,
then there may be a place for Caesarean section after cor-
rection of the clotting defect.
One of the practical difficulties in the management of
these patients is the correlation of the clinical state, the
serial investigations, and -the progress being made, with
the treatment given. To facilitate the management of these
patients we have modified the 'flow sheet' (Caillouette
et al.21) so that all necessary inform:lition is readily avail-
able.
The results obtained in the treatment of 45 patients with
hypofibrinogenaemia associated with abruptio placentae
are shown in Table 1.
TABLE I. RESULTS OF TRE....TMENT
Vaginal Deliveries; Total 34
(l) Without pitocin drip 24
(i1) With pitocin drip 9
(iil) With pitocin drip and Iow forceps
extraction ....
Lower-segment Caesarean Section; Total 10
(l) For obstetrical causes 5
(il) For failure to respond to treatment 5
Caesarean Hysterectomy; Total 1
The foetal mortality was 100% and 1 maternal death
occurred in this series. This occurred in a para 3 aged
28 years, who sustained a ruptured uterus during the
delivery of a hydrocephalic infant. The clotting defect
appeared late in treatment after the Caesarean hysterec-
tomy had been performed. She was given 18 pints of
blood and 15 G. of fibrinogen before she died. At post-
mortem examination the cause of death was found to be
a slipped ligature on the uterine artery.
Two patients developed acute pulmonary oedema during
treatment. This was ascribed in both to the excessive use
of triple-strength plasma. Both patients responded to
digitalization and venesection.
The complication of postpartum haemorrhage arose in
6 patients. In 4 of these, treatment of the clotting defect
was inadequate, and in the other two insufficient time
elap ed between admi ion and deli ery for ompletion
of adequate treatment.
Only in one patient severe oliguria occurred in associa-
tion with hypofibrinogenaemia. It occurred in a hyperten-
ive para 6, aged 26, who wa admitted with revealed and
concealed accidental haemorrhage, which had occurred 3
hours before admission. Her blood pressure was 170/120
romJIg on admi sion. Her lowest urinary output in 24
hour wa 150 m!. and the highest blood-urea recording
was 280 mg. per 100 ml. on the 9th day after delivery.
She responded well to treatment and was discharged.
Until a few years ago severe accidental haemorrhage
had always been associated with a high maternal mortality
in which acute renal failure played a large part. In 1950,
for instance, one of us (D.C., 1950"') found an anuria rate
of 11·6% and a maternal mortality rate of 10·9% in a
large series of patients treated at the Peninsula Maternity
Hospital, Cape Town.
In the present series the ingle maternal death was
mainly caused by factors other than the hypofibrinogenae-
mia, and the only case of observed oliguria occurred
where there was probably already some predisposing renal
arteriolar spa m with the hypertension associated with
unpreventable delay in the onset of treatment.
We ascribe these results to 3 ma,in principles of manage-
ment: Firstly, the rapid correction of the hypovolaemia
with blood; econdly, the rapid correction of the hypo-
fibrinogenaemja with adequate quantities of fibrinogen as
indicated by the clot-observation test and quantitative
fibrinogen estimation; and finally, refrajning from ex-
pediting vaginal delivery until the sitlJa,tion is well con-
trolled, with Cae arean section occupying an important
place in the treatment of patient with the complicatjon
of an unfavourable cervix, recurrence of hypofibrinoge-
naernia or shock, or a delayed on et of haemorrhage-
delivery interval.
SUMMARY
1. A study of 46 patients with serious hypofibrino-
genaemia is presented occurring among African and Indian
patients. Of these 44 were associated with evere con-
cealed accidental haemorrhage.
2. The frequency of liver dysfunction among the
Africans was considered a possible aetiological factor in
the high incidence of hypofibrinogenaemia found in
accidental haemorrhage (62'10) and among the total
deliveries (0·18%). Grande multiparity was also found to
predispose to hypofibrinogenaemia.
3. Both the hypovolaemia and the clotting defects were
found to be complications in accidental haemorrhage
which requjred correction as emergency measures - pre-
ferably within an hour of the admi ion of the patient.
T,he use .of fibI'inogen wa found to be preferable to that
of triple-strength plasma in uch circumstances.
4. Defibrinogenation is not always a 'once for all
mechanism', and the most serious cases are prone to
develop a recurrence of hypofibrinogenaemia following
the initial correction (particularly among our African
patients). Con equentIy Caesarean ection plays an im-
portant role in the treatment of evere ca es a ociated
with a prolonged interval between the on et of accidental
haemorrhage and the anticipated vaginal delivery.
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SALMONELLA BELLVILLE
VERDERE NUWE SEROTIPE (16: e,n,x : 1,7)
H. D. BREDE, DR. MED. PRIV. Doz. (KOLN)
Hoof, Deparlement van Mikrobiologie, Fakulteit van Geneeskunde, 'Universiteit van Stellenbosch en Karl Bremer-
hospitaal, Bellville, Kp.
Op 8 Julie 1960 het ons van een en dieselfde stoelgang-
monster, wat van 'n Blanke 10-jarige kind met koorsigheid,
braking, maagpyn, en 'n m~tige geelsug verkry is, tege-
lykertyd 'n patogene E. koli tipe 0 119 en 'n salmonella
gekweek. Onder kliniese behandeling het die pasient vinrug
verbeter.
Hierdie salmonella was nie teenwoordig in die Kauff-
mann-White skema rue. Die biochemiese reaksies was soos
volg: ureum, indol, KCN, laktose, saccharose, raffinose,
inosiet, eskulien, adoniet, en salisilaat: negatief. Daar
was SUUf- en gas-formasie in dekstrose, manniet, dulsiet
en sorbiet; slegs suur, maar geen gas nie, in eksilol; en
H2S-formasie was sterk positief. Alle positiewe reaksies
was binne 48 uur sigbaar.
Serologies het agglutinasie plaasgev1ind met die O-agglu-
tinien 16 en met die sweephaaragglutiniene e, n, en x, sodat
ons primer aan 'n tweede onspesif'ieke fase gedink het,
want die e,n,x-kombinasie is meestal kenmerkend daar-
van. Vir verdere bestudering is hierdie stam na die
SaImonella-sentrum in Londen gestuur en ondersoeke is
ook in Chamblee, Georgia (V.S.A.), en in Kopenhagen
gedoen. Die defirritiewe seroformule is as 16 : e,n,x : 1,7
bepaal. Aangesien die pasient in die omgewing van ons
hosp1taal woonagtig is, het ons vir die nuwe salmonella
die naam S. bellville voorgestel. Intussen is hierdie naam
internasionaal aanvaar. S. bellville is een van die skaars
tipes wat die e,n,x-kompleks as eerste spesifieke H-fase
het. (fot nog toe is daar slegs een ander salmonella met
e,n,x in die spesifieke fase, nl. S. lindrick.)
S. bellville was primer weerstandig teenoor penisillien,
eritromisien en novobiosien, maar gevoelig vir strepto-
misien, chloramfenikol, kanamisien, en aIle tetrasiklienes.
Salmonella bellville, A F'URTHER NEW SEROTYPE
(16 : e,n,x : 1,7)
This new salmonella was isola.ted from faeces of a 10-
year-old European boy from the neighbourhood of our
hospital. Simultaneously a pathogenic E. coli type 0 119
was obtained. Two months before hospitalization the
patient's faeces contained blood. On admission fever was-
present, together with vomiting, stomach cramps, and
moderate jaundice. The patient recovered quickly after a
few days of clinical tr~tment.
The following biochemical proper.ties were determined:
urea, indol, KCN, lactose, saccharose, raffinose, inositol,
aesculin, adonit, and salicin: negative. There was acid
and gas formation in dextrose, mannitol, dulcitol and
sorbitol; only acid formation in xylose; and H,S-produc-
tion was stormy. Gelatine was liquefied after 32 days.
On serological examination S. bellville was agglutinated
by the O-antiserum 16 and by the agglutinins e,n and x.
Therefore we thought ·the strain would be 'in the second
phase and posted it to the Salmonella Reference Labora-
tory, London, for further observations. Meanwhile the
definite sero-formula was determined as: 16: e,n,x : 1, .
The name S. bellville has been accepted internationally.
S. bellville was found to be primarily resistant to peni-
cillin, erythromycin and novobiocin, and sensitive to strep-
tomycin, chloramphenicol, kanamycin, neomycin, and all
the tetracyclines.
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